Fatima Karzai

National Institutes of Health

Papers

1

Total Citations

8

H-Index

1

About

Fatima Karzai is a clinical researcher whose work focuses on the intersection of advanced prostate cancer treatment and surgical precision. Her primary research areas include the role of neoadjuvant hormonal therapy—specifically antiandrogen and androgen deprivation therapy—in men undergoing robotic prostatectomy, and the use of multiparametric MRI (mpMRI) for preoperative staging. Her most-cited study, published in 2019, demonstrated how mpMRI can accurately assess tumor response and residual disease after hormonal therapy, offering a non-invasive tool to guide surgical planning. This work has been cited 8 times, reflecting its growing relevance in urologic oncology. Karzai’s contributions help bridge the gap between medical and surgical management of prostate cancer, potentially reducing overtreatment and improving outcomes for high-risk patients. Her research is notable for its practical, patient-centered approach—combining imaging biomarkers with therapeutic strategies to refine staging and personalize care. As a rising voice in the field, Karzai continues to explore how preoperative imaging can inform both prognosis and surgical decision-making, making her work valuable for clinicians and researchers seeking to optimize multimodal treatment pathways.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy
8 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago